☆ 4.4 Article

Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers

RSC MEDICINAL CHEMISTRY (2023)

Related references

Note: Only part of the references are listed.

Review Chemistry, Multidisciplinary

Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications

R. Tyler Mertens et al.

Summary: Gold drugs such as Myocrisin, Solganal, and Ridaura are used in the treatment of inflammatory arthritis. However, the development of new gold complexes has been slow. Repurposing the drug Ridaura for different diseases has led to the development of new gold complexes based on unique mechanisms. Various chemical methods for preparing stable gold complexes and their mechanisms have been explored for therapeutic purposes. This review focuses on the development of gold agents in biomedicine, providing readers with an overview of their utility and mechanism of action.

CHEMICAL REVIEWS (2023)

Add to Collection

Article Materials Science, Biomaterials

N-Acetylation of Biodegradable Supramolecular Peptide Nanofilaments Selectively Enhances Their Proteolytic Stability for Targeted Delivery of Gold-Based Anticancer Agents

Yaron Marciano et al.

Summary: Peptidematerials have potential for biomedical applications, but their lack of stability and rapid degradation in vivo due to non-specific proteolysis is a concern. In this study, we demonstrate that N-terminal acetylation of self-assembling peptides containing an MMP-9-cleavable segment improves proteolytic stability without impacting their assembly behavior or ability to encapsulate hydrophobic drugs. The acetylated peptides show enhanced stability in human plasma and retain susceptibility to MMP-9 hydrolysis, making them a promising candidate for clinical translation.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Promising heterometallic compounds as anticancer agents: Recent studies in vivo

Javier E. Lopez-Hernandez et al.

Summary: Over the past decade, there has been increased interest in multitarget anticancer drugs, including heterometallic compounds, which have shown improved efficacy and physicochemical properties compared to individual metallic fragments. Promising candidates against cisplatin resistant cancers have emerged, and this article summarizes research contributions to this topic over the past four years, particularly focusing on the in vivo activity and preliminary mechanisms of action of five groups of compounds. Two families of compounds based on Pt(IV)-Gd(III) and Ti(IV)-Au(I) metal combinations are highlighted for their potential clinical translation.

CURRENT OPINION IN CHEMICAL BIOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

Peng Liu et al.

Summary: Liposomes have been widely recognized as promising drug carriers due to their superior properties. This review discusses the liposomal drug products approved by FDA and EMA, providing valuable information on their critical chemistry and pharmaceutical technologies. Moreover, it summarizes the current regulatory guidance and future perspectives related to liposomal products.

MOLECULES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules

Rossana Galassi et al.

Summary: This article reviews recent scientific findings on two classes of gold compounds containing phosphane or carbene ligands, as well as the recent developments in the application of Auranofin for breast cancers.

BIOMOLECULES (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms

Neha Kaushik et al.

Summary: Nanocarriers (NCs) have attracted significant attention for their structural ability, good biocompatibility, and biodegradability. The development of NCs with stimuli-responsive properties has become a hot topic among scientists. These NCs can deliver drugs to tumors by regulating their pH, temperature, and enzyme responsiveness, thereby improving the accuracy of drug delivery and minimizing side effects. Material carriers for chemotherapeutic medicines are discussed in this review, with a focus on their structural properties and targeting methods that enhance therapeutic efficacy and trigger metabolic pathways. Overall, the development of NCs that respond to endogenous and exogenous stimuli in tumor regions and the understanding of their mechanisms have great potential for advancing tumor therapy and precision diagnosis in the future.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Add to Collection

Correction Materials Science, Biomaterials

A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents (vol 26, pg 1, 2022)

Veera Venkata Satya Naga Lakshmi Andra et al.

BIONANOSCIENCE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency

Yaron Marciano et al.

Journal of the American Chemical Society (2022)

Add to Collection

Review Pharmacology & Pharmacy

Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy

Jia Wang et al.

Summary: Nano-drug delivery systems, such as liposomes, have revolutionized tumor treatment by utilizing the unique pathophysiology of tumors to improve drug delivery and efficacy.

AAPS PHARMSCITECH (2021)

Add to Collection

Article Chemistry, Inorganic & Nuclear

Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model

Kirill Miachin et al.

Summary: The potential of ruthenium(II) compounds as an alternative to platinum-based clinical anticancer agents has been unveiled. Studies have shown that ruthenium compounds can be highly effective in treating cisplatin-resistant cell lines, including triple-negative breast cancer. Research indicates that certain ruthenium compounds with fluorophores have a preferential accumulation in the endoplasmic reticulum, mitochondria, and lysosomes.

INORGANIC CHEMISTRY (2021)

Add to Collection

Review Pharmacology & Pharmacy

A Review of Fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Breast Cancer

Xoan Nguyen et al.

Summary: Fam-trastuzumab deruxtecan-nxki is an effective treatment option for HER2-positive breast cancer in advanced, unresectable, or metastatic settings. Common adverse effects include fatigue, nausea, and hair loss, while serious adverse effects such as interstitial lung disease or embryo-fetal toxicity require careful monitoring. Randomized controlled trials are still needed to further evaluate its efficacy and safety in clinical practice.

ANNALS OF PHARMACOTHERAPY (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer

Nazia Nayeem et al.

Summary: This review focuses on the potential of coordination and organometallic compounds as chemotherapeutics for triple negative breast cancer (TNBC), which has poor prognoses and survival rates compared to other types of breast cancer. The review lists references for metal-based compounds studied in TNBC cell lines and in vivo, and aims to highlight the most promising metal-based compounds with potential as chemotherapeutic agents for TNBC.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

Add to Collection

Review Pharmacology & Pharmacy

A Review on Drug Delivery System for Tumor Therapy

Guoxiang Liu et al.

Summary: In recent years, the development of nanomaterials has led to a new field of cancer therapy focusing on drug delivery systems. These systems, such as drug nanoparticles, offer advantages like easy preparation, high efficiency, low toxicity, and active tumor targeting. Research in this area provides a theoretical basis for the future clinical application of personalized cancer nanomedicine.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Ultrasound-triggered herceptin liposomes for breast cancer therapy

Amal Elamir et al.

Summary: Functionalizing liposomes with monoclonal antibodies, particularly anti-HER2 antibodies, can enhance targeted drug delivery to HER2 positive breast cancer cells. Low frequency ultrasound (LFUS) triggered drug release from liposomes can be further enhanced by the conjugation of Trastuzumab, increasing drug uptake and cellular toxicity in HER2+ cell lines. Combining immunoliposomes with LFUS is a promising technique to improve drug delivery efficiency and reduce cytotoxicity of antineoplastic drugs.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Oncology

The gold complex auranofin: new perspectives for cancer therapy

Farah H. Abdalbari et al.

Summary: This article discusses the potential mechanisms of auranofin as a promising anti-cancer therapy, mainly targeting the oxidative stress and cell death system to inhibit cancer cell proliferation.

DISCOVER ONCOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

When liposomes met antibodies: Drug delivery and beyond

Jiaxing Di et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Add to Collection

Review Nanoscience & Nanotechnology

A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy

Weiwei Mu et al.

NANO-MICRO LETTERS (2020)

Add to Collection

Article Chemistry, Medicinal

Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity

Benelita T. Elie et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Add to Collection

Article Oncology

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Filippo Montemurro et al.

EUROPEAN JOURNAL OF CANCER (2019)

Add to Collection

Article Chemistry, Medicinal

Replaceinent of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer

Tiziano Marzo et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Add to Collection

Article Multidisciplinary Sciences

Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents

Jong Hyun Kim et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

Natalia Curado et al.

CHEMICAL COMMUNICATIONS (2019)

Add to Collection

Article Nanoscience & Nanotechnology

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Anne Rodallec et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)

Add to Collection

Review Chemistry, Multidisciplinary

Immunoliposomes in clinical oncology: State of the art and future perspectives

Maria Merino et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Add to Collection

Article Polymer Science

Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody-Trastuzumab: The New Approach of a Well-Known Strategy

Monika Marcinkowska et al.

POLYMERS (2018)

Add to Collection

Article Nanoscience & Nanotechnology

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

Anne Rodallec et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)

Add to Collection

Article Oncology

Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro Study

Lucyna Matusewicz et al.

CANCERS (2018)

Add to Collection

Article Pharmacology & Pharmacy

Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy

Josimar O. Eloy et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Add to Collection

Editorial Material Chemistry, Multidisciplinary

Attenuating the immunogenicity of PEGylated liposomes by gangliosides

Kinam Park

JOURNAL OF CONTROLLED RELEASE (2017)

Add to Collection

Article Chemistry, Medicinal

Auranofin, Et3PAuCl, and Et3PAul Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study

Tiziano Marzo et al.

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection

Article Oncology

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

Victor A. Gall et al.

CANCER RESEARCH (2017)

Add to Collection

Review Pharmacology & Pharmacy

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Jung Soo Suk et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Add to Collection

Article Chemistry, Multidisciplinary

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer

Sara Zalba et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Add to Collection

Article Biotechnology & Applied Microbiology

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Elvin Blanco et al.

NATURE BIOTECHNOLOGY (2015)

Add to Collection

Article Chemistry, Organic

How the Structural Elucidation of the Natural Product Stephanosporin Led to New Developments in Aryl Radical and Medicinal Chemistry

Stefanie K. Fehler et al.

SYNLETT (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo

Jacob Fernandez-Gallardo et al.

CHEMICAL SCIENCE (2015)

Add to Collection

Article Oncology

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri-Kordestani et al.

CLINICAL CANCER RESEARCH (2014)

Add to Collection

Article Chemistry, Medicinal

Ado-trastuzumab Emtansine (T-DM1): An Antibody-Drug Conjugate (ADC) for HER2-Positive Breast Cancer

John M. Lambert et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection

Article Multidisciplinary Sciences

Cholesterol level affects surface charge of lipid membranes in saline solution

Aniket Magarkar et al.

SCIENTIFIC REPORTS (2014)

Add to Collection

Article Chemistry, Inorganic & Nuclear

BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics

Semra Tasan et al.

DALTON TRANSACTIONS (2013)

Add to Collection

Article Chemistry, Medicinal

Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action

Joao Carlos Lima et al.

Anti-Cancer Agents in Medicinal Chemistry (2012)

Add to Collection

Review Pharmacology & Pharmacy

Tumor delivery of macromolecular drugs based on the EPR effect

Vladimir Torchilin

ADVANCED DRUG DELIVERY REVIEWS (2011)

Add to Collection

Article Biochemical Research Methods

Development of the Novel PEG-PE-Based Polymer for the Reversible Attachment of Specific Ligands to Liposomes: Synthesis and in Vitro Characterization

Swati Biswas et al.

BIOCONJUGATE CHEMISTRY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.